Chimaeric antigen receptor T-cell therapy for tumour immunotherapy. - Wikidata - thesis-toulmin - TriplyDB

Chimaeric antigen receptor T-cell therapy for tumour immunotherapy.

Chimaeric antigen receptor T-cell therapy for tumour immunotherapy.

http://www.wikidata.org/entity/Q37609801

about

Engineering CAR-T cells.

P2860

Q39399864-8F26FECF-4B6E-40DE-B75A-884E95E15EE5

P2860

Chimaeric antigen receptor T-cell therapy for tumour immunotherapy.

http://www.wikidata.org/entity/Q37609801

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Chimaeric antigen receptor T-cell therapy for tumour immunotherapy.

@en

Chimaeric antigen receptor T-cell therapy for tumour immunotherapy.

@nl

type

label

Chimaeric antigen receptor T-cell therapy for tumour immunotherapy.

@en

Chimaeric antigen receptor T-cell therapy for tumour immunotherapy.

@nl

prefLabel

Chimaeric antigen receptor T-cell therapy for tumour immunotherapy.

@en

Chimaeric antigen receptor T-cell therapy for tumour immunotherapy.

@nl

P1433

Q37609801-A66E5E6E-78D6-4030-AF1D-440CA24D0AE6

P1476

Q37609801-976E6395-B4F7-447D-B485-26F530C80F92

P2093

Q37609801-16ABEFF9-0C25-45A3-843A-24C7E9DBEEE9

Q37609801-30E4FF16-DC95-46D4-B490-0BD2B401B6B0

Q37609801-8A40CFF9-260C-403C-AB29-059540D65506

Q37609801-949D17B2-2521-4A73-BAA7-B34224FCE169

Q37609801-AA862DAA-13DE-442D-A450-88F8B885B94C

Q37609801-B9883928-C99B-4EDE-AECF-367692EAF785

Q37609801-F391FB09-6291-4A68-8D21-9729ACD77856

P275

Q37609801-D7EE79B3-693B-40CC-BA37-2A7C66C46BBB

P2860

Q37609801-06FA9887-2050-42D0-A026-5E594585E43C

Q37609801-084AB76A-A571-4E4E-9AD0-5845943385A1

Q37609801-08741D3E-8D1B-4FBC-BC83-3D4F62892D25

Q37609801-09D9F2ED-EF9B-4163-AD78-22B2A7BE73CB

Q37609801-16D56F24-BA5F-4421-AD41-047C1E8C3AF8

Q37609801-1787222B-FE5B-4CCA-B2F1-5BF020C690D1

Q37609801-191F8F96-B361-4064-9E79-E0DED399431E

Q37609801-1996A26A-524E-4B83-B837-2466D1B0148B

Q37609801-1B094BAB-A195-4C7E-97C0-E44B2FA8DC05

Q37609801-1B79EF07-76C5-4C9A-A8AF-A382170F31A4

P31

Q37609801-5E63F585-BEBD-40ED-8CAF-1A86F9664B9C

Q37609801-90337D22-3FF2-470E-89C9-E2E627D68235

P356

Q37609801-88EC8AEC-5A5E-4EEB-9166-99F2AD142DAD

P433

Q37609801-8B946743-3E52-4DDF-8CDA-179E9418ED67

P478

Q37609801-B78DC954-2505-48CD-B227-5443810CCB33

P5008

Q37609801-D6699EE9-AE3B-4EC3-9586-E3D1C2D64504

P577

Q37609801-0422E924-FC4D-49AC-AB14-3371C6934D7E

Q37609801-5947E0E2-8DA8-4AE4-825D-940A22CC2890

P698

Q37609801-50597616-87D3-49F8-8A0B-F2F5B597EFF4

P921

Q37609801-478F42F9-FDB2-4EA0-A65A-EA66861F3EC0

Q37609801-62785530-1848-4478-BBD2-B87913C64A14

Q37609801-9ECEA6AE-C877-43ED-9891-8DD3754F0459

Q37609801-A4A91122-CD29-4C02-847E-C76A4A031D66

Q37609801-E86AFFD0-ABFA-4AE0-B1EF-C5203DF2646C

P932

Q37609801-FE2B091B-A557-4609-955E-03694DBE26FC

P356

P1433

Bioscience Reports

P1476

Chimaeric antigen receptor T-cell therapy for tumour immunotherapy.

@en

P2093

Da-Li Yan

http://www.w3.org/2001/XMLSchema#string

Dan-Dan Wang

http://www.w3.org/2001/XMLSchema#string

Huan-Huan Sha

http://www.w3.org/2001/XMLSchema#string

Ji-Feng Feng

http://www.w3.org/2001/XMLSchema#string

Si-Wen Liu

http://www.w3.org/2001/XMLSchema#string

Su-Jin Yang

http://www.w3.org/2001/XMLSchema#string

Yong Hu

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy

Adoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptors

PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models

Are BiTEs the "missing link" in cancer therapy?

Chimeric antigen receptor T cells for sustained remissions in leukemia

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

Inducible apoptosis as a safety switch for adoptive cell therapy

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

P31

scholarly article

P356

10.1042/BSR20160332

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2017-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28053197

http://www.w3.org/2001/XMLSchema#string

P921

cell surface receptor

membrane proteins

hemic and immune systems

P932

5270315

http://www.w3.org/2001/XMLSchema#string